US Stock MarketDetailed Quotes

MAIA Biotechnology (MAIA)

Watchlist
  • 1.300
  • -0.010-0.76%
Trading May 28 11:44 ET
79.04MMarket Cap-1.91P/E (TTM)

MAIA Biotechnology (MAIA) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
216.78%34.41M
-9.82%8.66M
-9.82%8.66M
25.33%10.89M
-12.39%10.14M
31.33%10.86M
34.27%9.6M
34.27%9.6M
42.36%8.69M
26.60%11.58M
-Cash and cash equivalents
216.78%34.41M
-9.82%8.66M
-9.82%8.66M
25.33%10.89M
-12.39%10.14M
31.33%10.86M
34.27%9.6M
34.27%9.6M
42.36%8.69M
26.60%11.58M
Receivables
----
--0
--0
54.24%82.69K
-53.70%82.27K
-49.94%78.08K
-46.54%77.35K
-46.54%77.35K
-53.15%53.61K
-54.07%177.69K
-Other receivables
----
----
----
54.24%82.69K
-53.70%82.27K
-49.94%78.08K
-46.54%77.35K
-46.54%77.35K
-53.15%53.61K
-54.07%177.69K
Other current assets
-2.00%902.02K
120.29%1.04M
120.29%1.04M
57.47%780.52K
214.27%816.26K
237.69%920.47K
76.36%473.83K
76.36%473.83K
19.69%495.65K
6.74%259.73K
Total current assets
197.72%35.32M
-4.44%9.7M
-4.44%9.7M
27.22%11.75M
-8.10%11.04M
36.34%11.86M
34.22%10.15M
34.22%10.15M
39.30%9.24M
22.92%12.02M
Non current assets
Other non current assets
168.50%7.52K
0.00%2.8K
0.00%2.8K
867.32%27.09K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
Total non current assets
168.50%7.52K
0.00%2.8K
0.00%2.8K
867.32%27.09K
0.00%2.8K
-82.54%2.8K
0.00%2.8K
0.00%2.8K
-99.24%2.8K
-99.43%2.8K
Total assets
197.71%35.32M
-4.44%9.7M
-4.44%9.7M
27.47%11.78M
-8.10%11.05M
36.12%11.86M
34.21%10.16M
34.21%10.16M
32.02%9.24M
17.05%12.02M
Liabilities
Current liabilities
Payables
62.00%2.98M
34.80%2.04M
34.80%2.04M
175.65%3.18M
36.35%1.72M
-1.66%1.84M
-7.70%1.51M
-7.70%1.51M
-6.04%1.15M
-18.42%1.26M
-accounts payable
62.00%2.98M
34.80%2.04M
34.80%2.04M
175.65%3.18M
36.35%1.72M
-1.66%1.84M
-7.70%1.51M
-7.70%1.51M
-6.04%1.15M
-18.42%1.26M
Current accrued expenses
-7.95%1.83M
88.71%2.6M
88.71%2.6M
284.59%5.92M
95.50%2.73M
39.50%1.99M
-18.41%1.38M
-18.41%1.38M
-26.87%1.54M
21.15%1.39M
Current liabilities
25.01%6.32M
52.38%5.84M
52.38%5.84M
176.94%9.99M
43.66%5.04M
3.05%5.06M
-22.42%3.83M
-22.42%3.83M
-13.04%3.61M
7.28%3.51M
Non current liabilities
Derivative product liabilities
-33.64%1.24M
-44.53%1.49M
-44.53%1.49M
-56.52%1.75M
-60.25%2.13M
-80.52%1.86M
25.02%2.69M
25.02%2.69M
3,783.06%4.02M
4,296.91%5.35M
Total non current liabilities
-33.64%1.24M
-44.53%1.49M
-44.53%1.49M
-56.52%1.75M
-60.25%2.13M
-80.52%1.86M
25.02%2.69M
25.02%2.69M
3,783.06%4.02M
4,296.91%5.35M
Total liabilities
9.21%7.56M
12.39%7.33M
12.39%7.33M
53.99%11.74M
-19.06%7.17M
-52.20%6.92M
-8.02%6.52M
-8.02%6.52M
79.25%7.62M
160.95%8.86M
Shareholders'equity
Share capital
105.07%6.07K
47.67%3.86K
47.67%3.86K
43.76%3.45K
34.04%3.18K
43.71%2.96K
53.97%2.62K
53.97%2.62K
74.07%2.4K
73.92%2.37K
-common stock
105.07%6.07K
47.67%3.86K
47.67%3.86K
43.76%3.45K
34.04%3.18K
43.71%2.96K
53.97%2.62K
53.97%2.62K
74.07%2.4K
73.92%2.37K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-26.43%-116M
-25.67%-109.63M
-25.67%-109.63M
-26.70%-106M
-19.98%-97.1M
-27.35%-91.75M
-36.35%-87.23M
-36.35%-87.23M
-44.94%-83.66M
-53.13%-80.93M
Paid-in capital
48.66%143.8M
23.27%112.05M
23.27%112.05M
24.36%106.07M
20.09%101M
45.87%96.73M
40.99%90.9M
40.99%90.9M
40.94%85.29M
40.78%84.11M
Gains losses not affecting retained earnings
-3.96%-39.67K
-64.06%-50.23K
-64.06%-50.23K
-163.50%-30.84K
-35.40%-30.03K
-26.99%-38.16K
-88.28%-30.62K
-88.28%-30.62K
73.26%-11.7K
14.40%-22.18K
Total stockholders'equity
461.71%27.76M
-34.63%2.38M
-34.63%2.38M
-97.43%41.67K
22.61%3.88M
185.73%4.94M
661.16%3.63M
661.16%3.63M
-41.09%1.62M
-54.00%3.16M
Total equity
461.71%27.76M
-34.63%2.38M
-34.63%2.38M
-97.43%41.67K
22.61%3.88M
185.73%4.94M
661.16%3.63M
661.16%3.63M
-41.09%1.62M
-54.00%3.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 216.78%34.41M-9.82%8.66M-9.82%8.66M25.33%10.89M-12.39%10.14M31.33%10.86M34.27%9.6M34.27%9.6M42.36%8.69M26.60%11.58M
-Cash and cash equivalents 216.78%34.41M-9.82%8.66M-9.82%8.66M25.33%10.89M-12.39%10.14M31.33%10.86M34.27%9.6M34.27%9.6M42.36%8.69M26.60%11.58M
Receivables ------0--054.24%82.69K-53.70%82.27K-49.94%78.08K-46.54%77.35K-46.54%77.35K-53.15%53.61K-54.07%177.69K
-Other receivables ------------54.24%82.69K-53.70%82.27K-49.94%78.08K-46.54%77.35K-46.54%77.35K-53.15%53.61K-54.07%177.69K
Other current assets -2.00%902.02K120.29%1.04M120.29%1.04M57.47%780.52K214.27%816.26K237.69%920.47K76.36%473.83K76.36%473.83K19.69%495.65K6.74%259.73K
Total current assets 197.72%35.32M-4.44%9.7M-4.44%9.7M27.22%11.75M-8.10%11.04M36.34%11.86M34.22%10.15M34.22%10.15M39.30%9.24M22.92%12.02M
Non current assets
Other non current assets 168.50%7.52K0.00%2.8K0.00%2.8K867.32%27.09K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K
Total non current assets 168.50%7.52K0.00%2.8K0.00%2.8K867.32%27.09K0.00%2.8K-82.54%2.8K0.00%2.8K0.00%2.8K-99.24%2.8K-99.43%2.8K
Total assets 197.71%35.32M-4.44%9.7M-4.44%9.7M27.47%11.78M-8.10%11.05M36.12%11.86M34.21%10.16M34.21%10.16M32.02%9.24M17.05%12.02M
Liabilities
Current liabilities
Payables 62.00%2.98M34.80%2.04M34.80%2.04M175.65%3.18M36.35%1.72M-1.66%1.84M-7.70%1.51M-7.70%1.51M-6.04%1.15M-18.42%1.26M
-accounts payable 62.00%2.98M34.80%2.04M34.80%2.04M175.65%3.18M36.35%1.72M-1.66%1.84M-7.70%1.51M-7.70%1.51M-6.04%1.15M-18.42%1.26M
Current accrued expenses -7.95%1.83M88.71%2.6M88.71%2.6M284.59%5.92M95.50%2.73M39.50%1.99M-18.41%1.38M-18.41%1.38M-26.87%1.54M21.15%1.39M
Current liabilities 25.01%6.32M52.38%5.84M52.38%5.84M176.94%9.99M43.66%5.04M3.05%5.06M-22.42%3.83M-22.42%3.83M-13.04%3.61M7.28%3.51M
Non current liabilities
Derivative product liabilities -33.64%1.24M-44.53%1.49M-44.53%1.49M-56.52%1.75M-60.25%2.13M-80.52%1.86M25.02%2.69M25.02%2.69M3,783.06%4.02M4,296.91%5.35M
Total non current liabilities -33.64%1.24M-44.53%1.49M-44.53%1.49M-56.52%1.75M-60.25%2.13M-80.52%1.86M25.02%2.69M25.02%2.69M3,783.06%4.02M4,296.91%5.35M
Total liabilities 9.21%7.56M12.39%7.33M12.39%7.33M53.99%11.74M-19.06%7.17M-52.20%6.92M-8.02%6.52M-8.02%6.52M79.25%7.62M160.95%8.86M
Shareholders'equity
Share capital 105.07%6.07K47.67%3.86K47.67%3.86K43.76%3.45K34.04%3.18K43.71%2.96K53.97%2.62K53.97%2.62K74.07%2.4K73.92%2.37K
-common stock 105.07%6.07K47.67%3.86K47.67%3.86K43.76%3.45K34.04%3.18K43.71%2.96K53.97%2.62K53.97%2.62K74.07%2.4K73.92%2.37K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -26.43%-116M-25.67%-109.63M-25.67%-109.63M-26.70%-106M-19.98%-97.1M-27.35%-91.75M-36.35%-87.23M-36.35%-87.23M-44.94%-83.66M-53.13%-80.93M
Paid-in capital 48.66%143.8M23.27%112.05M23.27%112.05M24.36%106.07M20.09%101M45.87%96.73M40.99%90.9M40.99%90.9M40.94%85.29M40.78%84.11M
Gains losses not affecting retained earnings -3.96%-39.67K-64.06%-50.23K-64.06%-50.23K-163.50%-30.84K-35.40%-30.03K-26.99%-38.16K-88.28%-30.62K-88.28%-30.62K73.26%-11.7K14.40%-22.18K
Total stockholders'equity 461.71%27.76M-34.63%2.38M-34.63%2.38M-97.43%41.67K22.61%3.88M185.73%4.94M661.16%3.63M661.16%3.63M-41.09%1.62M-54.00%3.16M
Total equity 461.71%27.76M-34.63%2.38M-34.63%2.38M-97.43%41.67K22.61%3.88M185.73%4.94M661.16%3.63M661.16%3.63M-41.09%1.62M-54.00%3.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The plot took a sharp turn! At a White House cabinet meeting on May 27, Trump publicly expressed dissatisfaction with the negotiations, reje Show More